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Homeostatic disruptor agents, and endocrine disruptor compounds (EDC) specifically, can originate from agricultural and
industrial chemicals. If they modify the adaptation of living organisms as direct (e.g., by altering hormone regulation, membrane
functions) and/or indirect (e.g., cell transformation mechanisms) factors, they are classified as EDC. We aimed to examine the
potential endocrine-disrupting effects of phenylurea herbicides (phenuron, monuron, and diuron) on the oxytocin (OT) and
arginine-vasopressin (AVP) release of neurohypophysis cell cultures (NH). In our experiments, monoamine-activated receptor
functions of neurohypophyseal cells were used as a model. In vitro NH were prepared by enzymatic (trypsin, collagenase) and
mechanical dissociation. In the experimental protocol, the basal levels of OT and AVP were determined as controls. Later,
monoamine (epinephrine, norepinephrine, serotonin, histamine, and dopamine) activation (10−6M, 30min) and the effects of
phenylurea (10−6M, 60min) alone and in combination (monoamines 10−6M, 30min + phenylureas 10−6M, 60min) with
monoamine were studied. OT and AVP hormone contents in the supernatant media were measured by radioimmunoassay. The
monoamine-activated receptor functions of neurohypophyseal cells were modified by the applied doses of phenuron, monuron,
and diuron. It is concluded that the applied phenylurea herbicides are endocrine disruptor agents, at least in vitro for
neurohypophysis function.
1. Introduction
Nowadays, society is the most complex evolutionary scene,
in which transactions are realized between human beings
and their environment (including the atmosphere, hydro-
sphere, and lithosphere). In this relation, people modify
their environment so as to maintain their existence (e.g.,
chemisation) [1]. Chemisation came to be as a result of the
biological and ecological problems caused by the vast and
ever increasing amounts of chemicals used in agriculture
(pesticides, herbicides, and fertilizers) [2]. These chemicals
are xenobiotics [3]. These days, persistent organic pollutants
(POPs) are placed in the focus. Endocrine disruptor
compounds (EDC) are a group of heterogeneous POPs,
which can interfere with endocrine communication [4, 5].
Phenylurea herbicides as POPs inhibit photosynthesis and
can be found as contaminants in surface water and ground-
water [6, 7]. Phenylureas have been used in agriculture
extensively because of their herbicidal properties [8]. Sev-
eral of the chlorinated benzenes are known to be por-
phyrogenic, carcinogenic, and mutagenic in animals and
humans [9]; EDC lead to anxiety and aggression in rats
[10] and to predator avoidance and reproductive and
social behaviors in fish [7].
Biological objects, in order to maintain their inner
homeostatic balance, take inputs from their environment,
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which can induce system accommodation processes. This
connection among the biotic and abiotic systems can
materialize, e.g., via neuroendocrine communication [11].
The synthesis and release of endogenous oxytocin (OT)
and arginine-vasopressin (AVP) can be induced by exter-
nal stimuli from paraventricular, supraoptic, and suprachi-
asmatic nuclei. The nerve terminals in the posterior lobe
of the pituitary gland store these peptide hormones and
release them into blood vessels to provoke their biological
functions [12, 13].
OT secretion induced by stimuli is inversely propor-
tional to the inhibition of food intake and gastric motility
and stimulates the release of somatostatin and gastrin [14].
On the other hand, the actions of OT modulate neuroendo-
crine reflexes to establish complex social behaviors [15].
Beyond its peripheral effects on reproductive organs, OT
might have an effect on neurons responsible for the cogni-
tive feelings of organisms [16]. It is known that AVP and
OT affect social cognition, particularly the acquisition and
retention of social recognition in rats and mice [17]. Both
hypotension and extracellular fluid volume expansion
appear to stimulate hypothalamic oxytocinergic neurons
and OT secretion; in rats, OT increases blood pressure and
pulse rate [18]. There are several published studies investi-
gating the prosocial effects of OT in humans: behaviors that
facilitate interpersonal relations, including trusting behav-
ior, generosity, and cooperation [19, 20]. In the female
reproductive system, the pregnant uterus is one of the tra-
ditional targets of OT [21]. Systematic OT could also act
peripherally, stimulating smooth muscle cells of the male
reproductive tract [20].
The peptidergic hormone AVP can also be released by
external stimuli and plays roles as both neurotransmitter
and neuromodulator in the brain [22]. AVP participates in
the regulation of the cardiovascular system and
water-electrolyte balance [23]. As an antidiuretic hormone,
AVP regulates body osmolality, blood volume, and blood
pressure [24]. From these studies, it is postulated that OT
and AVP are crucial in the adaptation processes of living
organisms [25].
In homeostatic balance, biogenic amines play an essen-
tial role in the regulation of AVP and OT. Biogenic amines
(with the ability to activate or inhibit OT and AVP) are
important in the response mechanisms to external inputs.
It is well documented that neuronal systems contain bio-
genic amines, such as dopamine (DA), epinephrine (E), nor-
epinephrine (NE), histamine (HA), and serotonin (5-HT).
These mediators may contribute reinforcement information
to influence memory performance [26, 27].
The monoamine-regulated OT and AVP release
serves as a model for the study of neuroendocrine cell
function [28–32].
The integrity of neuroendocrine regulation can be con-
trolled by following endocrine function attractors in in vitro
models [33, 34]. Such regulation attractor in the OT and
AVP secretion in vitro model is the monoamine-activated
(agonistic or antagonistic) hormone secretion result.
Homeostatic regulation is modified by environmental
factors (e.g., presence of EDC). The effects of EDC factors
do not impact on the baseline but on the regulation of
attractors [35]. When studying subtoxic or low-dose
in vitro models, the regulation attractor should be followed
for a worthy effect.
Our purpose was to present contemporary research in
connection with the complex environmental stressors and
their effects on the equilibrium process of living systems.
We investigated the potential endocrine-disrupting effects
of phenylurea herbicides (phenuron-PU, monuron-MU,
and diuron-DU) on the monoamine-regulated oxytocin
and vasopressin release of neurohypophysis cell cultures.
2. Materials and Methods
2.1. Experimental Protocol.Male Wistar rats (Charles River,
Isaszeg, Hungary, medically certified) from different litters
(weighing 120-250 g, aged 4-6 weeks at the beginning of
the research) were used for hypophysis cell culture model
systems. The animal care and research protocols were in
full accordance with the guidelines of the University of
Szeged, Hungary. During the research period, rats were
kept under controlled relative air humidity of 55-65%
and 22 ± 2°C ambient temperature. Experimental animals
lived under automated diurnal conditions (12 h darkness
and 12 h light system) in groups of 10 animals. Standard
pellet food and tap water were available ad libitum. After
pentobarbital anaesthesia (4.5mg/kg b.w. Nembutal,
Abbott, USA), the animals were killed and decapitated.
Neurohypophysis and adenohypophysis tissues were sepa-
rated under a preparative microscope.
The neurohypophysis tissue was digested enzymatically
with 0.2% trypsin (Sigma, Germany) in phosphate-buffered
saline for 60min and with 0.05% collagenase (Sigma, Ger-
many) for an additional 60min at 37°C. The enzymatic
hydrolysis was stopped by the addition of 100μg/mL trypsin
inhibitor (Sigma, Germany). Mechanical disintegration of
the tissue was performed on nylon blutex sieves (pore sizes
100, 80, and 48μm in series). Cultures were controlled for
both viability (>95%; trypan blue exclusion) and function,
and the cell density was determined to be 2× 105 cells/mL.
The dispersed cells were placed onto 24-well plastic plates
(Costar, USA) coated with 5% rat-tail collagen (Sigma, Ger-
many). The starting cell density was 2 × 105 cells/mL of
medium (Dulbecco’s modified Eagle’s medium; Sigma, Ger-
many) supplemented with 20% foetal calf serum (Gibco,
USA) and 100μg/L PENSTREP (Sigma, Germany). The cell
cultures were maintained at 37°C in a humidified atmosphere
of 5% CO2 in air. The culture medium was changed every 3
days. The 14-day-old neurohypophysis primary cell cultures
were standardised by immunohistochemical methods (by
relative incidence/unit plate-area of IR content OT or AVP
cells), and the OT and AVP time-release kinetic activity
was determined.
After these procedures, the basal OT and AVP levels
were measured in neurohypophysis cell cultures.
2.2. Cell Culture Treatment Protocol (Figure 1). The control
samples were untreated and served as self-controls, which
showed the basal release (60min) of OT and AVP in NH.
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The effects of PU, MU, and DU added to the NH for
60 minutes at concentration of 10−6M were examined one
by one [36]: PU CAS registry number: 101-42-8, DU CAS
registry number: 330-54-1, and MU CAS registry number:
150-68-5 (Sigma, Germany). In our earlier studies,
dose-dependent kinetics of phenylurea agents were deter-
mined, and the experimental doses were selected, because
the saturation of receptor-binding sites depends on the
affinity and number of receptor-binding molecules.
Monoamine-activated G-protein receptors in NH were
treated with 10−6M (E, NE, 5-HT, HA, and DA)
(Figures 2(a) and 2(b)) for 30min [28–32] and the same
concentration (10−6M) of phenylurea agents.
The combined treatment groups of the NH were treated
firstly with monoaminergic compounds (for 30min), then
phenylurea compounds (for 60min): (1) E+PU, NE+PU,
5-HT+PU, HA+PU, and DA+PU; (2) E+MU, NE+MU,
5-HT+MU, HA+MU, and DA+MU; and (3) E+DU, NE
+DU, 5-HT+DU, HA+DU, and DA+DU.
The OT and AVP contents were detected in the superna-
tant media. From the supernatant media, 500μL samples
were removed by Gilson pipette at appropriate times and
stored at −80°C until peptide radioimmunoassay (RIA) was
performed to measure OT and AVP [10, 37].
A modified Lowry method [38] and Pierce BCA Protein
Assay Kit (Thermo Fisher Scientific Inc., Rockford, USA)
were used for the determination of total protein content.
2.3. Statistical Analysis. Pooled samples of neurohypophysis
cell cultures (12 lots) were measured for OT and AVP
hormone release in different EDC groups (control, PU,
MU, and DU) by monoamine regulation (basal, E, NE,
5-HT, HA, and DA) in rats (n = 10 or 12 per group). Data
were analyzed using mixed models [39–41]. The mono-
amine regulation cycle was verified in mixed models for
the comparison of 6 monoamine levels in the control
groups for OT and for AVP. In the random intercept
model, monoamine was used as the fixed factor and the
lots as the intercept.
For the two investigated hormone data (OT, AVP),
mixed models were applied with EDC and monoamine as
fixed effects and random intercept for the lots. In the analy-
sis models, the reference group was the control (no EDC
treatment) basal (no monoamine) group.
Restricted maximum likelihood estimation and the
Kenward-Roger method for adjusting the degrees of free-
dom were applied in all models with unstructured covari-
ance matrix. Pairwise comparisons were estimated by least
squares means using Šidák p value adjustment. Model resid-
uals were checked for normality assumptions.
Statistical analyses were performed in SAS (Version 9.3
SAS Institute Inc., Cary, NC, USA), where p values of <0.05
were considered to indicate statistical significance [42].
3. Results
Stability of homeostatic systems can be followed by examin-
ing the endocrine regulation cycle. Therefore, the
monoamine-activated OT/AVP release cycles were modelled
by NH in vitro.
NH monolayer
Determination of OT/AVP level
from supernatant
+ [PU], [MU], [DU]: 10−6 M
60 min








Figure 1: The in vitro treatment protocol. PU: phenuron; DU: diuron; MU: monuron; E: epinephrine; NE: norepinephrine; 5-HT: serotonin;
HA: histamine; DA: dopamine; OT: oxytocin; AVP: arginine-vasopressin.
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The result of PU, MU, and DU alone on neurohypophy-
sis cell culture can be seen in Figures 3(a) and 3(b). OT
release was not modified significantly by treatment with
MU or DU, but PU (176 67 ± 1 25 ng OT/mg protein) can
modulate it compared to the control (153 13 ± 0 63 ng
OT/mg protein). AVP release did not show significant dif-
ference in the case of phenylurea agents.
OT and AVP release is an indicator of the
monoamine-activated receptor cycle of neurohypophysis
cells. The changing of these mechanisms was investigated using
phenylurea agents (Figures 4 and 5). E (292 81 ± 1 49 ng
OT/mg protein) activated OT secretion (153 13 ± 0 63 ng
OT/mg protein) (Figure 4(a)) was significantly decreased
by PU (268 71 ± 1 07 ng OT/mg protein) and DU
(255 ± 0 10 ng OT/mg protein). Figure 4(b) shows the effects
of phenylureas on NE activation. MU (252 47 ± 4 75 ng
OT/mg protein) and DU (277 09 ± 1 10 ng OT/mg protein)
significantly reduced the effect of NE (316 55 ± 1 36 ng
OT/mg protein). OT exocytosis induced by 5-HT is shown
in Figure 4(c). The used phenylurea agents caused only
discrete changing of OT release in NH. In the case of HA
(292 91 ± 3 16 ng OT/mg protein), only the combination
with DU (264 89 ± 1 39 ng OT/mg protein) reduced the
OT release significantly as seen in Figure 4(d). Figure 4(e)
shows OT secretion for DA (342 06 ± 2 65 ng OT/mg pro-
tein), and again, only the combination with DU
(318 72 ± 1 74 ng OT/mg protein) decreased it significantly.
In the case of AVP hormone, the E (212 41 ± 0 59 pg
AVP/mg protein) activation was modified significantly by PU
(193 01 ± 0 54 pg AVP/mg protein), DU (182 94 ± 0 59 pg
AVP/mg protein), and MU (230 18 ± 0 55 pg AVP/mg pro-
tein) (Figure 5(a)). NE (231 33 ± 2 41 pg AVP/mg protein)
induced AVP release (Figure 5(b)) was reduced by PU
(211 96 ± 0 49 pg AVP/mg protein), MU (203 95 ± 0 64 pg
AVP/mg protein), and DU (201 19 ± 0 52 pg AVP/mg pro-
tein). The effects of 5-HT (194 11 ± 0 49 pg AVP/mg protein)
on NH cell AVP release (Figure 5(c)) were decreased by PU
(172 88 ± 0 43 pg AVP/mg protein) and MU (163 70 ± 0 54 pg
AVP/mg protein) and increased by DU (214 44 ± 0 90 pg
































































Figure 2: The effect of monoamines on OT (a) and AVP (b) release in neurohypophysis cell cultures. Pairwise comparisons verified the
regulation cycle: all monoamine [10−6M] groups increased significantly (∗∗∗p < 0 0001) compared to the basal regulation in control OT








































Figure 3: The effect of phenylureas [10−6M] on OT (a) and AVP (b) secretion in neurohypophysis cell cultures. (a) n = 12, mean ngOT/
mg protein ± Std; ∗p < 0 01. (b) n = 10, mean pgAVP/AVP protein ± Std.
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of HA (131 65 ± 0 53 pg AVP/mg protein) induced AVP
release was diminished by PU (113 55 ± 0 72 pg AVP/mg
protein) andDU(105 48 ± 0 89 pgAVP/mgprotein). TheDA
(172 11 ± 0 94 pg AVP/mg protein) receptor-mediated AVP
release (Figure 5(e)) in NH was significantly depressed by PU
(138 72 ± 0 65 pg AVP/mg protein), MU (143 19 ± 0 71 pg
AVP/mg protein), and DU (146 34 ± 1 24 pgAVP/mg protein).
4. Discussion and Conclusions
Bretaud et al. pointed out that exposures to sublethal con-
centrations of carbofuran, DU, and nicosulfuron have
remarkable effects on acetylcholinesterase activity in the
brain of goldfish (Carassius auratus) [43]. It is described that
the herbicide MU inhibits growth and heterocyst formation
in the nitrogen-fixing cyanobacterium Nostoc muscorum
[44]. The results of Federico et al. showed direct genotoxic
activity caused by the effects of PU, DU, and difenoxuron,
as is demonstrated by the increasing number of chromo-
somal aberrations and sister chromatid exchange in Chinese
hamster ovary and epithelial cell lines [45]. However, there is
a serious lack of information on the effects of these agents on
the endocrine cells.
In neuroendocrine communication, monoamines are
known to be relevant regulators for the hormone release.
Earlier studies have established that α1 receptors are
involved in the E-induced increase in OT and AVP secre-
tion, while the β2 receptor has a role in NE-mediated OT
and AVP secretion. 5-HT1 and 5-HT2 receptors are involved
in the 5-HT-induced increase in OT secretion while only
5-HT2 receptor has a role in the AVP secretion in NH.




















































































































Figure 4: The effect of 10−6M phenylureas on OT release in NH via 10−6M monoamine-activated receptor functions. n = 12; mean
ngOT/mg protein ± Std; ∗p < 0 01 and ∗∗p < 0 001. OT: oxytocin; PU: phenuron; MU: monuron; DU: diuron; E: epinephrine; NE:
norepinephrine; 5-HT: serotonin; HA: histamine; DA: dopamine.
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the HA-induced increase in OT and AVP release in neuro-
hypophysis cell cultures. D1 receptors are involved in the
DA-induced enhancement of OT and AVP secretion. All
mentioned monoamine receptors are G-protein-coupled,
and cAMP-mediated mechanisms are induced in cells. OT
and AVP hormone secretion is realized through protein
kinase-C mechanisms (Figures 2(a) and 2(b)) [20, 46, 47].
In our in vitro model system, the EDC effects were
detected by following hormone release via the disturbance of
monoamine receptor function. The phenylureas alone did
not show effects on basal hormone secretion of NH
(Figure 3(b)), expect for PU on OT release (Figure 3(a)). How-
ever, the neurohypophysis cell function was modified by the
combined treatment of monoamines and PU, MU, and DU.
With regard to OT secretion, PU has an effect in epinephrine
activation (Figure 4). MU has a stronger effect in NE activa-
tion. E, NE, HA, and DA activation was decreased signifi-
cantly by the effect of diuron. In the phenylurea homologue
line, the used DU was twice chloro substituted which can
explain the difference in the endocrine effect [48, 49].
With regard to AVP release, the effects of used phenylur-
eas were more expressed in all monoamine activation
(Figure 5). PU had a significant effect on E, NE, 5-HT,
HA, and DA monoamine activation. E activation was
enhanced, and NE, 5-HT, and DA activation was reduced
significantly by the used dose of MU (with the exception of
HA activation). DU increased serotonin activation and
decreased E, NE, HA, and DA monoamine activation sig-
nificantly. These results are interesting in the case of AVP

















































































































Figure 5: The effect of 10−6M phenylureas on AVP release in NH via 10−6M monoamine-activated receptor functions. n = 10; mean pg
AVP/mg protein ± Std; ∗p < 0 01 and ∗∗p < 0 001; AVP: arginine-vasopressin; PU: phenuron; MU: monuron; DU: diuron; E: epinephrine;
NE: norepinephrine; 5-HT: serotonin; HA: histamine; DA: dopamine.
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hormone has an essential role in the endocrine-regulating
body of osmolality, blood volume, blood pressure, cell con-
traction, and proliferation [23, 50]. The abovementioned
hormones play a crucial role in horizontal homeostatic regu-
lation; thus, altering the secretion of OT and AVP may influ-
ence the adaptation processes of living organisms to the
external environment.
These findings confirm the classification of phenylureas
as EDC. The environmental pollution by EDC may have
chronic and/or acute effects on living organisms. Our results
showed that the applied doses of phenylurea herbicides have
direct and indirect effects on biological systems. Presumably,
these phenylurea herbicides can disturb the association of
monoamines to their receptors. The applied EDC per se play
the role of possible modulator agents. In this context, neuro-
hypophysis function is a crucial conditioning process.
E-, NE-, HA-, 5-HT-, and DA-activated hormone release
mechanisms are mediated G-protein-coupled receptors [28,
29, 51]. These processes induce Gq/G11 proteins, which, in
turn, activate phospholipase-C, which catalyses the hydroly-
sis of phosphatidylinositol 4,5-bisphosphate to yield inositol
triphosphate and diacylglycerol [52–54]. These signal trans-
ducers can enhance the intracellular [Ca2+] which is essen-
tial for OT and AVP expression. A detailed understanding
of the mechanisms of hormone expression and functions is
required to fully understand the workings of EDC, particu-
larly the possibility that low doses of PU, MU, and DU
might interfere with monoaminergic receptors.
In conclusion, the effects of phenylurea herbicides on
monoamine-induced OT and AVP release show an EDC
character based our results of an in vitro model system.
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